These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 13502041)

  • 21. Mannomustine in treatment of leukaemias, polycythaemia, and malignant disorders.
    BARLOW AM; LEEMING JT; WILKINSON JF
    Br Med J; 1959 Aug; 2(5146):208-13. PubMed ID: 13671231
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical evaluation of CB 1348 in malignant lymphoma and related diseases.
    ISRAELS LG; GALTON DA; TILL M; WILTSHAW E
    Ann N Y Acad Sci; 1958 Apr; 68(3):915-25. PubMed ID: 13627740
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of CB-1348 (chlorambucil, leukeran) and CB-1364.
    RUNDLES W; GRIZZLE J; BONO VH; JONSSON U; HUGULEY CM; CORLEY CC
    Cancer Chemother Rep; 1962 Feb; 16():223-30. PubMed ID: 14495284
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent advances in treatment of leukemias and lymphomas.
    IRWIN GE
    W V Med J; 1952 Sep; 48(9):262-4. PubMed ID: 13006097
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of CB 1348 in Hodgkin's disease and allied disorders.
    BOURONCLE BA; DOAN CA; WISEMAN BK; FRAJOLA WJ
    AMA Arch Intern Med; 1956 Jun; 97(6):703-14. PubMed ID: 13312712
    [No Abstract]   [Full Text] [Related]  

  • 26. [Indication of the use of beta-naphthyl-di-2-chloroethylamine, in Hodgkin's disease and Leukemia].
    RAMIOUL H
    Acta Unio Int Contra Cancrum; 1955; 11(2):167-9. PubMed ID: 13248724
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical trials of p-(di-2-chloroethylamino)-phenylbutyric acid (CB 1348) in malignant lymphoma.
    GALTON DA; ISRAELS LG; NABARRO JD; TILL M
    Br Med J; 1955 Nov; 2(4949):1172-6. PubMed ID: 13269823
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapeutic results in treatment of Hodgkin's disease with CB 1348 and R-48.
    ROTTINO A
    Blood; 1957 Aug; 12(8):755-65. PubMed ID: 13446003
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of the leukemias and lymphomas; current trends.
    SYKES MP
    J Am Med Womens Assoc; 1952 Sep; 7(9):321-5. PubMed ID: 12990488
    [No Abstract]   [Full Text] [Related]  

  • 30. [A new derivative of yperite for oral and intramuscular administration: bis-(2-chloroethyl) beta-naphthylamine in cancer].
    RAMIOUL H
    Acta Clin Belg; 1954; 9(5):401-63. PubMed ID: 13217644
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic effect of small doses of chloroethylaminohydrochloride associated with roentgenotherapy in blastomatosis].
    HOLY J; SUCHAN M
    Cas Lek Cesk; 1953 Mar; 92(10):255-8. PubMed ID: 13051787
    [No Abstract]   [Full Text] [Related]  

  • 32. Hematological changes following treatment with p-(di-2-chlorethylamino)-phenylbutyric acid (CB 1348) in cancer. I. Effect on lymphocytes and platelets.
    PILLERS EK; MAGALINI SI
    Cancer; 1958; 11(2):410-5. PubMed ID: 13511361
    [No Abstract]   [Full Text] [Related]  

  • 33. Chemotherapy in the reticuloses.
    MELICK RA
    Med J Aust; 1952 Jan; 1(2):38-43. PubMed ID: 14909886
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapeutic value of certain anticellular substances in erythroblastic blood diseases].
    ROMEO G
    Acta Paediatr Lat; 1952; 5(2):214-22. PubMed ID: 14943538
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of malignant lymphomas and lymphadenoses with leukeran.
    LIBANSKY J; CHUDOMEL V; BRABEC V; SOCHMAN J
    Neoplasma; 1959; 6():415-24. PubMed ID: 14416684
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of leukemia with urethane and nitrogen mustards].
    CHILOV K; IVANOV S
    Izv Meditsinskite Inst Bulg Akad Naukite Sofia Otd Biol Meditsinski Nauki; 1951; 4-5():9-38. PubMed ID: 14937908
    [No Abstract]   [Full Text] [Related]  

  • 37. [Profuse cutaneous lymphosis; clearing with combined cortisone and chloraminophen].
    THIERS H; COLOMB D; FAYOLLE J; ARCADIO F; NOVE JOSSERAND
    Bull Soc Fr Dermatol Syphiligr; 1959; 66():201-2. PubMed ID: 13837805
    [No Abstract]   [Full Text] [Related]  

  • 38. Hematological changes following treatment with p-(di-2-chlorethylamino)-phenylbutyric acid (CB 1348) in cancer. II. Effect on erythroid and myeloid cells in blood and bone marrow.
    MAGALINI SI; PILLERS EK
    Cancer; 1958; 11(2):416-20. PubMed ID: 13511362
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of chemotherapy in the management of malignant lymphomas and leukemias.
    RUNDLES RW; BARTON WB; COONRAD EV
    South Med J; 1953 Mar; 46(3):259-68. PubMed ID: 13038539
    [No Abstract]   [Full Text] [Related]  

  • 40. Chlorambucil in childhood cancer.
    PINKEL D
    Cancer; 1961; 14():36-41. PubMed ID: 13735856
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.